Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Biotech
Harmony's pivotal trial flops as placebo response causes discord
Two years after picking up ZYN002 despite a midphase flop, the biotech has reported that a registrational trial missed its primary endpoint.
Nick Paul Taylor
Sep 24, 2025 9:35am
BMS reports phase 3 win in multiple myeloma
Sep 23, 2025 8:20am
Ionis rare disease candidate ekes out phase 3 win
Sep 22, 2025 10:46am
Roche reports phase 3 breast cancer victory for oral SERD
Sep 22, 2025 7:25am
One-third of data collected in trials may be unnecessary: study
Sep 19, 2025 11:01am
Roivant reports phase 3 autoimmune win for ex-Pfizer asset
Sep 17, 2025 7:00am